NCT05464823View on ClinicalTrials.gov

Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

May 12, 2027

Study Completion Date

May 12, 2027

Conditions
Lymphoma
Interventions
OTHER

Molecular Functional Portrait

Participants will be asked to allow previously-collected tumor tissue to be used for the MF Portrait test

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER